The Chinese mainland's forward-thinking policies aimed at fostering new productive forces, especially in the pharmaceutical sector, are bearing fruit. Leading international medical companies are not only increasing their investments but also expanding their operations within the region.
During a visit to the Beijing Economic-Technological Development Area, CGTNās Zhu Zhu explored how some of the worldās most renowned pharmaceutical firms have tapped into the potential presented by this innovative zone. The supportive regulatory environment and strategic incentives are attracting significant attention from global industry giants seeking to establish a strong foothold in the burgeoning Chinese market.
As these companies ramp up their presence, the local economy is experiencing a surge in technological advancements and job creation, further cementing the Chinese mainland's status as a pivotal hub for pharmaceutical innovation and growth.
Reference(s):
China's policies drive growth of global pharmaceutical giants
cgtn.com
